Alternative Commercialisation Models Offer Lifeline to Future of Gene Therapies

Written By Dean A. Wetherbee

https://www.pharmaceutical-technology.com/features/alternative-commercialisation-model-gene-therapy-ultra-rare-disease/

Dean A. Wetherbee
Previous

New Initiative Aims to Revive Stalled Rare Disease Therapies
Next

Alternative Development & Commercialization Strategies for Rare Disease Gene Therapies